Aspen Aerogels, Inc. (NYSE:ASPN) Shares Acquired by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise increased its position in Aspen Aerogels, Inc. (NYSE:ASPN) by 37.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,593 shares of the construction company’s stock after acquiring an additional 1,252 shares during the period. Banque Cantonale Vaudoise’s holdings in Aspen Aerogels were worth $81,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Federated Hermes Inc. increased its holdings in shares of Aspen Aerogels by 53.9% in the 4th quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock worth $18,211,000 after acquiring an additional 404,042 shares during the period. AIGH Capital Management LLC increased its holdings in shares of Aspen Aerogels by 3.0% in the 4th quarter. AIGH Capital Management LLC now owns 1,804,484 shares of the construction company’s stock worth $28,475,000 after acquiring an additional 52,462 shares during the period. Mesirow Institutional Investment Management Inc. bought a new position in Aspen Aerogels in the 4th quarter valued at about $12,015,000. Sargent Investment Group LLC grew its position in Aspen Aerogels by 24.1% in the 4th quarter. Sargent Investment Group LLC now owns 337,281 shares of the construction company’s stock valued at $5,322,000 after buying an additional 65,571 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in Aspen Aerogels by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 3,445,887 shares of the construction company’s stock valued at $29,635,000 after buying an additional 14,013 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Price Performance

NYSE ASPN opened at $24.74 on Tuesday. The stock has a market capitalization of $1.88 billion, a P/E ratio of -56.23 and a beta of 2.29. Aspen Aerogels, Inc. has a 1 year low of $5.32 and a 1 year high of $31.74. The business’s fifty day moving average is $25.15 and its two-hundred day moving average is $18.55. The company has a debt-to-equity ratio of 0.24, a quick ratio of 3.29 and a current ratio of 4.01.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Wednesday, May 1st. The construction company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.14. The company had revenue of $94.50 million for the quarter, compared to analysts’ expectations of $73.04 million. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. On average, research analysts forecast that Aspen Aerogels, Inc. will post 0.16 earnings per share for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, SVP Corby C. Whitaker sold 55,159 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total transaction of $1,379,526.59. Following the sale, the senior vice president now directly owns 131,533 shares of the company’s stock, valued at approximately $3,289,640.33. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other Aspen Aerogels news, SVP Keith L. Schilling sold 20,000 shares of the business’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $26.84, for a total transaction of $536,800.00. Following the sale, the senior vice president now directly owns 28,792 shares of the company’s stock, valued at approximately $772,777.28. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Corby C. Whitaker sold 55,159 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total transaction of $1,379,526.59. Following the sale, the senior vice president now directly owns 131,533 shares in the company, valued at $3,289,640.33. The disclosure for this sale can be found here. Insiders have sold a total of 3,832,103 shares of company stock valued at $91,679,369 in the last three months. 4.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

ASPN has been the subject of a number of recent analyst reports. B. Riley increased their target price on shares of Aspen Aerogels from $24.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, May 3rd. Piper Sandler increased their target price on shares of Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a research report on Wednesday, May 29th. HC Wainwright increased their target price on shares of Aspen Aerogels from $20.00 to $25.00 and gave the company a “buy” rating in a research report on Friday, May 3rd. TheStreet upgraded shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research report on Wednesday, March 6th. Finally, Canaccord Genuity Group increased their target price on shares of Aspen Aerogels from $18.00 to $28.00 and gave the company a “buy” rating in a research report on Friday, May 3rd. One analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $30.75.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.